85. Final 5-Year Safety and Efficacy Results of a Phase 3, Randomized, Placebo-Controlled Trial of Golimumab in Patients with Active Rheumatoid Arthritis Despite Previous Anti-Tumor Necrosis Factor Therapy
Smolen, Josef S., Kay, Jonathan, Landewe, Robert, Matteson, Eric K., Gaylis, Norman, Wollenhaupt, J., Murphy, Frederick T., Han, Chenglong, Gathany, Tim, Xu, Stephen, Zhou, Yiying, Hsia, Elizabeth C.,Volume:
53
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keu101.006
Date:
April, 2014
File:
PDF, 41 KB
english, 2014